SE437024B - Forfarande for framstellning av spiro-hydantoinforeningar - Google Patents

Forfarande for framstellning av spiro-hydantoinforeningar

Info

Publication number
SE437024B
SE437024B SE7711053A SE7711053A SE437024B SE 437024 B SE437024 B SE 437024B SE 7711053 A SE7711053 A SE 7711053A SE 7711053 A SE7711053 A SE 7711053A SE 437024 B SE437024 B SE 437024B
Authority
SE
Sweden
Prior art keywords
spiro
process according
product
hydrogen
imidazolidine
Prior art date
Application number
SE7711053A
Other languages
English (en)
Swedish (sv)
Other versions
SE7711053L (sv
Inventor
R Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/767,803 external-priority patent/US4117230A/en
Application filed by Pfizer filed Critical Pfizer
Publication of SE7711053L publication Critical patent/SE7711053L/xx
Publication of SE437024B publication Critical patent/SE437024B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems
SE7711053A 1976-10-18 1977-10-03 Forfarande for framstellning av spiro-hydantoinforeningar SE437024B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73306276A 1976-10-18 1976-10-18
US05/767,803 US4117230A (en) 1976-10-18 1977-02-11 Hydantoin derivatives as therapeutic agents

Publications (2)

Publication Number Publication Date
SE7711053L SE7711053L (sv) 1978-04-19
SE437024B true SE437024B (sv) 1985-02-04

Family

ID=27112515

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7711053A SE437024B (sv) 1976-10-18 1977-10-03 Forfarande for framstellning av spiro-hydantoinforeningar

Country Status (29)

Country Link
JP (3) JPS5353653A (de)
AR (1) AR220901A1 (de)
AT (1) AT356136B (de)
AU (1) AU504978B2 (de)
BG (1) BG28847A3 (de)
CA (1) CA1088945A (de)
CH (1) CH625511A5 (de)
DD (1) DD131931A5 (de)
DE (4) DE2759543C2 (de)
DK (1) DK150302C (de)
ES (1) ES463267A1 (de)
FI (1) FI62307C (de)
FR (1) FR2367754A1 (de)
GB (1) GB1566171A (de)
GR (1) GR70201B (de)
HK (1) HK53881A (de)
IE (1) IE45805B1 (de)
IL (1) IL53094A0 (de)
KE (1) KE3167A (de)
LU (1) LU78330A1 (de)
MX (1) MX4899E (de)
MY (1) MY8200157A (de)
NL (1) NL167434C (de)
NO (1) NO148453C (de)
NZ (1) NZ185358A (de)
PH (1) PH15639A (de)
PT (1) PT67164B (de)
SE (1) SE437024B (de)
YU (1) YU40821B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives
US4147797A (en) * 1978-08-11 1979-04-03 Pfizer Inc. Spiro-furanohydantoin derivatives
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4283409A (en) * 1979-10-29 1981-08-11 Pfizer Inc. Imidazolone derivatives
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
DE3262294D1 (en) * 1981-05-13 1985-03-28 Ici Plc Pharmaceutical compositions containing spiro succinimide derivatives
JPS58213717A (ja) * 1982-01-20 1983-12-12 Eisai Co Ltd ヒダントイン誘導体を含有する治療用薬剤
JPS59500617A (ja) * 1982-04-15 1984-04-12 アルコン・ラボラトリ−ズ・インコ−ポレ−テッド ヒダントイン治療剤
HU193191B (en) * 1982-12-06 1987-08-28 Pfizer Process for preparing spiro-hetero-azolones
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
HU198051B (en) * 1984-10-30 1989-07-28 Pfizer Process for producing spiro square brackets open imidazolidine-4,5'(6h)-quinoline square brackets closed-2,5-dione derivatives
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―3―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
JPS6357588A (ja) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤
MX12896A (es) * 1987-09-04 1993-06-01 Pfizer Procedimiento para preparar un compuesto de espiro-heteroazolonas
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
CA2482035A1 (en) * 2002-04-18 2003-10-30 University Of Virginia Patent Foundation Novel sodium channel blockers
FR2955107B1 (fr) 2010-01-08 2012-03-02 Servier Lab Nouveaux derives thiochromanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE2449030A1 (de) * 1974-10-11 1976-05-20 Schering Ag Neue pyridin-derivate
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents

Also Published As

Publication number Publication date
AU504978B2 (en) 1979-11-01
MY8200157A (en) 1982-12-31
NL167434C (nl) 1981-12-16
FR2367754A1 (fr) 1978-05-12
DK150302B (da) 1987-02-02
HK53881A (en) 1981-11-13
DE2746244C2 (de) 1983-05-19
DD131931A5 (de) 1978-08-09
MX4899E (es) 1982-12-14
DK461377A (da) 1978-04-19
YU40821B (en) 1986-06-30
FI773060A (fi) 1978-04-19
DE2759543C2 (de) 1987-04-09
AT356136B (de) 1980-04-10
JPS5353653A (en) 1978-05-16
PT67164A (en) 1977-11-01
AU2943177A (en) 1979-04-12
LU78330A1 (fr) 1979-06-01
GB1566171A (en) 1980-04-30
JPS5495575A (en) 1979-07-28
JPS5940388B2 (ja) 1984-09-29
NL7711358A (nl) 1978-04-20
NO773548L (no) 1978-04-19
IE45805B1 (en) 1982-12-01
YU244277A (en) 1982-08-31
BG28847A3 (en) 1980-07-15
DE2759542C2 (de) 1988-07-07
FR2367754B1 (de) 1982-07-09
DE2759927C2 (de) 1986-12-04
IL53094A0 (en) 1977-12-30
DK150302C (da) 1987-09-28
JPS5534132B2 (de) 1980-09-04
NZ185358A (en) 1979-06-08
ATA745977A (de) 1979-09-15
CH625511A5 (en) 1981-09-30
GR70201B (de) 1982-08-31
NO148453B (no) 1983-07-04
ES463267A1 (es) 1978-07-16
JPS5495570A (en) 1979-07-28
SE7711053L (sv) 1978-04-19
DE2746244A1 (de) 1978-04-20
NO148453C (no) 1983-10-12
FI62307B (fi) 1982-08-31
JPS607997B2 (ja) 1985-02-28
CA1088945A (en) 1980-11-04
FI62307C (fi) 1982-12-10
PT67164B (en) 1979-03-20
IE45805L (en) 1978-04-18
AR220901A1 (es) 1980-12-15
KE3167A (en) 1981-11-06
PH15639A (en) 1983-03-11
NL167434B (nl) 1981-07-16

Similar Documents

Publication Publication Date Title
SE437024B (sv) Forfarande for framstellning av spiro-hydantoinforeningar
CA1088073A (en) Hydantoin therapeutic agents
US4117230A (en) Hydantoin derivatives as therapeutic agents
US4147795A (en) Hydantoin derivatives as therapeutic agents
IE47726B1 (en) Thienohydantoin derivatives
EP0363793B1 (de) Arylalkoxycumarine, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel
SE447731B (sv) Spiro-polycykliska imidazolidindionderivat
JP5366211B2 (ja) アルドース還元酵素阻害活性を有する縮合三環化合物
EP0363796A1 (de) Heterocyclische substituierte Alkoxycumarine, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel
EP0033617A2 (de) Thiazolidin-Derivate und ihre Herstellung und deren medizinischen Zusammensetzungen
EP0470006B1 (de) Thioharnstoffderivate und sie enthaltendes antimikrobielles Mittel und sie enthaltendes Mittel gegen Magengeschwüre
US6071953A (en) Sulfonamide-substituted chromans, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
PL133220B1 (en) Method of obtaining new derivatives of oxazolidinodiene-2,4
HU203548B (en) Process for producing benzoxazine derivatives and pharmaceutical compositions containing them
US4209630A (en) Hydantoin derivatives as therapeutic agents
KR950001040B1 (ko) 티오우레아 유도체 및 이를 함유하는 항균제 및 항궤양제
EP0259930A1 (de) Derivate von Phenyl-, Pyrrolidin-2-yl-substituierten 5-Ring Heterocyclen mit antipsychotischer Wirkung
CA1140928A (en) Aldose reductase inhibiting quinolylhydantions
EP0025109B1 (de) 1-Benzoxepin-5(2H)-on-Derivate und ihre Salze sowie Verfahren zu deren Herstellung
US4282229A (en) Hydantoin derivatives as therapeutic agents
JPH05331161A (ja) クロモン誘導体及び該化合物を有効成分とするアルドー スリダクターゼ阻害剤
US4177282A (en) Hydantoin therapeutic agents
US4210756A (en) Tetrahydroquinoline hydantoins for chronic diabetic complications
US4258054A (en) Hydantoin derivatives as therapeutic agents
KR950003499B1 (ko) 1,3,5-트리티안 유도체

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7711053-4

Effective date: 19940510

Format of ref document f/p: F